FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ake Borg

Research Profile

Disorders

Genes & Molecular Sequences

Physiology

Chemicals & Drugs

Concepts & Ideas

Phenomena

Nucleic Acid Hybridization

Co-author Network

Publications

TOP 3
Susanne Magnusson; David Gisselsson; Ulf Kristoffersson; Thomas Wiebe; Ake Borg; Håkan Olsson
Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Karolina Holm; Jillian Howlin; Kristina Lövgren; Per Malmström; Steina Aradottir; Pär-Ola Bendahl; Stephen Ethier; Mårten Fernö; Dorthe Grabau; Sofia Gruvberger-Saal; Cecilia Hegardt; Lisa Rydén; Lao H Saal; Olle Stål; Ake Borg; Markus Ringnér
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Laura Partanen; Johan Staaf; Minna Tanner; Vilppu J Tuominen; Ake Borg; Jorma Isola
Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ake Borg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Susanne Magnusson; David Gisselsson; Ulf Kristoffersson; Thomas Wiebe; Ake Borg; Håkan Olsson
Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
Pediatric blood & cancer 2012;59(5):846-53.
2012: Karolina Holm; Jillian Howlin; Kristina Lövgren; Per Malmström; Steina Aradottir; Pär-Ola Bendahl; Stephen Ethier; Mårten Fernö; Dorthe Grabau; Sofia Gruvberger-Saal; Cecilia Hegardt; Lisa Rydén; Lao H Saal; Olle Stål; Ake Borg; Markus Ringnér
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
Molecular oncology 2012;6(5):494-506.
2012: Laura Partanen; Johan Staaf; Minna Tanner; Vilppu J Tuominen; Ake Borg; Jorma Isola
Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer.
Genes, chromosomes & cancer 2012;51(9):832-40.
2012: Karolina Holm; Göran Jönsson; Linda Magnusson; Markus Ringnér; Johan Staaf; Johan Vallon-Christersson; Adalgeir Arason; Rosa B Barkardottir; Haukur Gunnarsson; Cecilia Hegardt; Ake Borg
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
Breast cancer research and treatment 2012;133(2):583-94.
2011: Ida Johansson; Göran Jönsson; Lena Luts; Heli Nevanlinna; Cecilia Nilsson; Håkan Olsson; Markus Ringnér; Johan Staaf; Carina Strand; Rosa B Barkardottir; Pontus Berglund; Ake Borg; Marie-Louise Fjällskog; Ingrid Hedenfalk
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.
Breast cancer research and treatment 2011;129(3):747-60.
2011: Mads Thomassen; Ida Vogel; Finn C Nielsen; Inge Søkilde Pedersen; Lone Sunde; Marie Luise Bisgaard; Ake Borg; Charlotte Brasch-Andersen; Claus L Brasen; Dorthe Crüger; Anne-Marie Gerdes; Thomas V O Hansen; Uffe B Jensen; Torben A Kruse
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing.
Breast cancer research and treatment 2011;128(1):179-85.
2011: Johan Staaf; Bo Baldetorp; Göran Jönsson; Markus Ringnér; Ake Borg
Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
Breast cancer research : BCR 2011;13(6):R129.
2011: Eleonor Olsson; Markus Ringnér; Lao H Saal; Johan Vallon-Christersson; Pär-Ola Bendahl; Ake Borg; Mårten Fernö; Dorthe Grabau; Sofia Gruvberger-Saal; Karolina Holm; Gabriella Honeth; Göran Jönsson; Kristina Lövgren; Cecilia Hegardt
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
BMC cancer 2011;11():418.
2011: Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Ake Borg; Rainer Fagerholm; Dario Greco; Päivi Heikkilä; Kati Kämpjärvi; Outi Kilpivaara; Heli Nevanlinna
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.
Breast cancer research : BCR 2011;13(5):R90.
2011: Helena Persson; Anders Kvist; Natalia Rego; Johan Staaf; Johan Vallon-Christersson; Lena Luts; Niklas Loman; Goran Jonsson; Hugo Naya; Mattias Hoglund; Ake Borg; Carlos Rovira
Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene.
Cancer research 2011;71(1):78-86.
2010: Katja Harbst; Johan Staaf; Anna Måsbäck; Håkan Olsson; Christian Ingvar; Johan Vallon-Christersson; Markus Ringnér; Ake Borg; Göran Jönsson
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Melanoma research 2010;20(5):381-91.
2010: Katarina Domanska; Susanne Malander; Johan Staaf; Anna Karlsson; Ake Borg; Göran Jönsson; Mef Nilbert
Genetic profiles distinguish different types of hereditary ovarian cancer.
Oncology reports 2010;24(4):885-95.
2010: Kari Nielsen; Katja Harbst; Anna Måsbäck; Göran Jönsson; Ake Borg; Håkan Olsson; Christian Ingvar
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Melanoma research 2010;20(4):266-72.
2010: Anna Isinger-Ekstrand; Jan Johansson; Mattias Ohlsson; Princy Francis; Johan Staaf; Mats Jönsson; Ake Borg; Mef Nilbert
Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array--comparative genomic hybridization.
Cancer genetics and cytogenetics 2010;200(2):120-6.
2010: Anna Isinger Ekstrand; Mats Jönsson; Annika Lindblom; Ake Borg; Mef Nilbert
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer.
Familial cancer 2010;9(2):125-9.
2010: Johan Staaf; Markus Ringnér; Johan Vallon-Christersson; Göran Jönsson; Pär-Ola Bendahl; Karolina Holm; Adalgeir Arason; Haukur Gunnarsson; Cecilia Hegardt; Bjarni A Agnarsson; Lena Luts; Dorthe Grabau; Mårten Fernö; Per-Olof Malmström; Oskar Th Johannsson; Niklas Loman; Rosa B Barkardottir; Ake Borg
Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1813-20.
2010: Ake Borg; Robert W Haile; Kathleen E Malone; Marinela Capanu; Ahn Diep; Therese Törngren; Sharon Teraoka; Colin B Begg; Duncan C Thomas; Patrick Concannon; Lene Mellemkjaer; Leslie Bernstein; Lina Tellhed; Shanyan Xue; Eric R Olson; Xiaolin Liang; Jessica Dolle; Anne-Lise Børresen-Dale; Jonine L Bernstein
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
Human mutation 2010;31(3):E1200-40.
2010: Johan Staaf; Ake Borg
Zoom-in array comparative genomic hybridization (aCGH) to detect germline rearrangements in cancer susceptibility genes.
Methods in molecular biology (Clifton, N.J.) 2010;653():221-35.
2010: Adalgeir Arason; Haukur Gunnarsson; Gudrun Johannesdottir; Kristjan Jonasson; Pär-Ola Bendahl; Elizabeth M Gillanders; Bjarni A Agnarsson; Göran Jönsson; Katri Pylkäs; Aki Mustonen; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Beatrice Melin; Oskar T H Johannsson; Pål Møller; Robert Winqvist; Heli Nevanlinna; Ake Borg; Rosa B Barkardottir
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
Breast cancer research : BCR 2010;12(4):R50.
2010: Göran Jönsson; Johan Staaf; Johan Vallon-Christersson; Markus Ringnér; Karolina Holm; Cecilia Hegardt; Haukur Gunnarsson; Rainer Fagerholm; Carina Strand; Bjarni A Agnarsson; Outi Kilpivaara; Lena Luts; Päivi Heikkilä; Kristiina Aittomäki; Carl Blomqvist; Niklas Loman; Per Malmström; Håkan Olsson; Oskar Th Johannsson; Adalgeir Arason; Heli Nevanlinna; Rosa B Barkardottir; Ake Borg
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Breast cancer research : BCR 2010;12(3):R42.
2010: Karolina Holm; Cecilia Hegardt; Johan Staaf; Johan Vallon-Christersson; Göran Jönsson; Håkan Olsson; Ake Borg; Markus Ringnér
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Breast cancer research : BCR 2010;12(3):R36.
2010: Johan Staaf; Göran Jönsson; Markus Ringnér; Johan Vallon-Christersson; Dorthe Grabau; Adalgeir Arason; Haukur Gunnarsson; Bjarni A Agnarsson; Per-Olof Malmström; Oskar T Johannsson; Niklas Loman; Rosa B Barkardottir; Ake Borg
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Breast cancer research : BCR 2010;12(3):R25.
2009: Helena Persson; Anders Kvist; Johan Vallon-Christersson; Patrik Medstrand; Ake Borg; Carlos Rovira
The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs.
Nature cell biology 2009;11(10):1268-71.
2009: Ana Carneiro; Princy Francis; Pär-Ola Bendahl; Josefin Fernebro; Måns Akerman; Christopher Fletcher; Anders Rydholm; Ake Borg; Mef Nilbert
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
Laboratory investigation; a journal of technical methods and pathology 2009;89(6):668-75.
2009: Srinivas Veerla; David Lindgren; Anders Kvist; Attila Frigyesi; Johan Staaf; Helena Persson; Fredrik Liedberg; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Carlos Rovira; Mattias Höglund
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
International journal of cancer. Journal international du cancer 2009;124(9):2236-42.
2009: Martin Augsten; Christina Hägglöf; Eleonor Olsson; Claudia Stolz; Panagiotis Tsagozis; Tetyana Levchenko; Mitchell J Frederick; Ake Borg; Patrick Micke; Lars Egevad; Arne Ostman
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(9):3414-9.
2009: Eva Henriksson; Elisabeth Kjellén; Bo Baldetorp; Pär-Ola Bendahl; Ake Borg; Eva Brun; Fredrik Mertens; Tomas Ohlsson; Karin Rennstam; Johan Wennerberg; Peter Wahlberg
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
Journal of experimental & clinical cancer research : CR 2009;28():17.
2008: Jia-Jing Lee; Amy Y M Au; Theodoros Foukakis; Michela Barbaro; Nimrod Kiss; Roderick J Clifton-Bligh; Johan Staaf; Ake Borg; Leigh Delbridge; Bruce G Robinson; Göran Wallin; Anders Höög; Catharina Larsson
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
Endocrine-related cancer 2008;15(3):801-15.
2008: Rebeqa Gunnarsson; Johan Staaf; Mattias Jansson; Anne Marie Ottesen; Hanna Göransson; Ulrika Liljedahl; Ulrik Ralfkiaer; Mahmoud Mansouri; Anne Mette Buhl; Karin Ekström Smedby; Henrik Hjalgrim; Ann-Christine Syvänen; Ake Borg; Anders Isaksson; Jesper Jurlander; Gunnar Juliusson; Richard Rosenquist
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.
Genes, chromosomes & cancer 2008;47(8):697-711.
2008: Johan Staaf; Therese Törngren; Eva Rambech; Ulla Johansson; Camilla Persson; Gunilla Sellberg; Lina Tellhed; Mef Nilbert; Ake Borg
Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).
Human mutation 2008;29(4):555-64.
2008: Ekaterina Kuchinskaya; Mats Heyman; Ann Nordgren; Jacqueline Schoumans; Johan Staaf; Ake Borg; Stefan Söderhäll; Dan Grandér; Magnus Nordenskjöld; Elisabeth Blennow
Array-CGH reveals hidden gene dose changes in children with acute lymphoblastic leukaemia and a normal or failed karyotype by G-banding.
British journal of haematology 2008;140(5):572-7.
2008: K Nielsen; A Masback; A Bladstrom; L Lundgren; Nils Jonsson; Ake Borg; Christian Ingvar; Håkan Olsson
Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
The British journal of dermatology 2008;158(2):429-31.
2008: Kazutoyo Osoegawa; Gery M Vessere; K H Utami; M Adela Mansilla; M K Johnson; Bridget M Riley; J L'Heureux; Rolph Pfundt; Johan Staaf; Walter A Van Der Vliet; Andrew C Lidral; Eric F P M Schoenmakers; Ake Borg; Brian C Schutte; Edward J Lammer; Jeffrey C Murray; P J de Jong
Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation.
Journal of medical genetics 2008;45(2):81-6.
2008: Josefin Fernebro; Ana Carneiro; Anders Rydholm; Henryk A Domanski; Anna Karlsson; Ake Borg; Mef Nilbert
Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.
Sarcoma 2008;2008():431019.
2008: Johan Staaf; Johan Vallon-Christersson; David Lindgren; Gunnar Juliusson; Richard Rosenquist; Mattias Höglund; Ake Borg; Markus Ringnér
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios.
BMC bioinformatics 2008;9():409.
2008: Johan Staaf; David Lindgren; Johan Vallon-Christersson; Anders Isaksson; Hanna Göransson; Gunnar Juliusson; Richard Rosenquist; Mattias Höglund; Ake Borg; Markus Ringnér
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays.
Genome biology 2008;9(9):R136.
2008: David Lindgren; Sigurdur Gudjonsson; Kowan Ja Jee; Fredrik Liedberg; Sonja Aits; Anna Andersson; Gunilla Chebil; Ake Borg; Sakari Knuutila; Thoas Fioretos; Wiking Månsson; Mattias Höglund
Recurrent and multiple bladder tumors show conserved expression profiles.
BMC cancer 2008;8():183.
2008: Gabriella Honeth; Pär-Ola Bendahl; Markus Ringnér; Lao H Saal; Sofia K Gruvberger-Saal; Kristina Lövgren; Dorthe Grabau; Mårten Fernö; Ake Borg; Cecilia Hegardt
The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Breast cancer research : BCR 2008;10(3):R53.
2008: Mads Thomassen; Thomas V O Hansen; Ake Borg; Henriette Theilmann Lianee; Friedrik Wikman; Inge Søkilde Pedersen; Marie Luise Bisgaard; Finn C Nielsen; Torben A Kruse; Anne-Marie Gerdes
BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(4):772-7.
2008: Markus Heidenblad; David Lindgren; Tord Jonson; Fredrik Liedberg; Srinivas Veerla; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Mattias Höglund
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
BMC medical genomics 2008;1():3.
2008: Magdalena Ratajska; Izabela Brozek; Elzbieta Senkus-Konefka; Jacek Jassem; Magdalena Stepnowska; Grazia Palomba; Marina Pisano; Milena Casula; Giuseppe Palmieri; Ake Borg; Janusz Limon
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Oncology reports 2008;19(1):263-8.
2008: Lao H Saal; Sofia K Gruvberger-Saal; Camilla Persson; Kristina Lövgren; Mervi Jumppanen; Johan Staaf; Göran Jönsson; Maira M Pires; Matthew Maurer; Karolina Holm; Susan Koujak; Shivakumar Subramaniyam; Johan Vallon-Christersson; Håkan Olsson; Tao Su; Lorenzo Memeo; Thomas Ludwig; Stephen Ethier; Morten Krogh; Matthias Szabolcs; Vundavalli Murty; Jorma Isola; Hanina Hibshoosh; Ramon Parsons; Ake Borg
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
Nature genetics 2008;40(1):102-7.
2007: Oscar Persson; Morten Krogh; Lao H Saal; Elisabet Englund; Jian Liu; Ramon Parsons; Nils Mandahl; Ake Borg; Bengt Widegren; Leif G Salford
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
Journal of neuro-oncology 2007;85(1):11-24.
2007: Jian Huang; Arief Gusnanto; Kathleen O'Sullivan; Johan Staaf; Ake Borg; Yudi Pawitan
Robust smooth segmentation approach for array CGH data analysis.
Bioinformatics (Oxford, England) 2007;23(18):2463-9.
2007: Josef Davidsson; Anna Andersson; Kajsa Paulsson; Markus Heidenblad; Margareth Isaksson; Ake Borg; Jesper Heldrup; Mikael Behrendtz; Ioannis Panagopoulos; Thoas Fioretos; Bertil Johansson
Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3.
Human molecular genetics 2007;16(18):2215-25.
2007: Emelie Svensson; Karina Vidovic; Tor Olofsson; Johan Vallon-Christersson; Ake Borg; Urban Gullberg
The Wilms' tumor gene 1 (WT1) induces expression of the N-myc downstream regulated gene 2 (NDRG2).
DNA and cell biology 2007;26(8):589-97.
2007: Göran Jönsson; C Dahl; Johan Staaf; Therese Sandberg; Pär-Ola Bendahl; Markus Ringnér; P Guldberg; Ake Borg
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Oncogene 2007;26(32):4738-48.
2007: Göran Jönsson; Johan Staaf; Eleonor Olsson; Markus Heidenblad; Johan Vallon-Christersson; Kazutoyo Osoegawa; Pieter de Jong; Stina Oredsson; Markus Ringnér; Mattias Höglund; Ake Borg
High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Genes, chromosomes & cancer 2007;46(6):543-58.
2007: Ekaterina Kuchinskaya; Ann Nordgren; Mats Heyman; Jacqueline Schoumans; Martin Corcoran; Johan Staaf; Ake Borg; Stefan Söderhäll; Dan Grandér; Magnus Nordenskjöld; Elisabeth Blennow
Tiling-resolution array-CGH reveals the pattern of DNA copy number alterations in acute lymphoblastic leukemia with 21q amplification: the result of telomere dysfunction and breakage/fusion/breakage cycles?
Leukemia 2007;21(6):1327-30.
2007: Lao H Saal; Peter Johansson; Karolina Holm; Sofia K Gruvberger-Saal; Qing-Bai She; Matthew Maurer; Susan Koujak; Adolfo Ferrando; Per-Uno Malmstrom; Lorenzo Memeo; Jorma Isola; Pär-Ola Bendahl; Neal Rosen; Hanina Hibshoosh; Markus Ringnér; Ake Borg; Ramon Parsons
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(18):7564-9.
2007: Jorune Balciuniene; Ningping Feng; Kelly Iyadurai; Betsy Hirsch; Lawrence Charnas; Brent R Bill; Mathew C Easterday; Johan Staaf; Leann Oseth; Desiree Czapansky-Beilman; Dimitrios Avramopoulos; George H Thomas; Ake Borg; David Valle; Lisa A Schimmenti; Scott B Selleck
Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities.
American journal of human genetics 2007;80(5):938-47.
2007: Peter Gustavsson; Jacqueline Schoumans; Johan Staaf; Ake Borg; Magnus Nordenskjöld; Göran Annerén
Duplication 16q12.1-q22.1 characterized by array CGH in a girl with spina bifida.
European journal of medical genetics 2007;50(3):237-41.
2007: Sofia K Gruvberger-Saal; Pär-Ola Bendahl; Lao H Saal; Mervi Laakso; Cecilia Hegardt; Patrik Edén; Carsten Peterson; Per Malmström; Jorma Isola; Ake Borg; Mårten Fernö
Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):1987-94.
2007: M Henningson; U Johansson; Ake Borg; Håkan Olsson; Helena Jernström
CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
Molecular human reproduction 2007;13(4):231-6.
2007: Jacqueline Schoumans; Josephine Wincent; Michela Barbaro; Tatjana Djureinovic; Paula Maguire; Lena Forsberg; Johan Staaf; Ann Charlotte Thuresson; Ake Borg; Ann Nordgren; Gunilla Malm; Britt-Marie Anderlid
Comprehensive mutational analysis of a cohort of Swedish Cornelia de Lange syndrome patients.
European journal of human genetics : EJHG 2007;15(2):143-9.
2007: Karin Rennstam; Göran Jönsson; Minna Tanner; Pär-Ola Bendahl; Johan Staaf; Anita I Kapanen; Ritva Karhu; Bo Baldetorp; Ake Borg; Jorma Isola
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
Cancer genetics and cytogenetics 2007;172(2):95-106.
2007: CP Lundin; Markus Heidenblad; B Strombeck; Ake Borg; Randi Hovland; Sverre Heim; Bertil Johansson
Tiling resolution array CGH of dic(7;9)(p11 approximately 13;p11 approximately 13) in B-cell precursor acute lymphoblastic leukemia reveals clustered breakpoints at 7p11.2 approximately 12.1 and 9p13.1.
Cytogenetic and genome research 2007;118(1):13-8.
2007: Johan Vallon-Christersson; Johan Staaf; Anders Kvist; Patrik Medstrand; Ake Borg; Carlos Rovira
Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray.
BMC genomics 2007;8():295.
2007: Maria Henningson; Erika Bågeman; Therese Sandberg; Ake Borg; Håkan Olsson; Helena Jernström
Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.
Familial cancer 2007;6(4):445-52.
2007: Mervi Jumppanen; Sofia Gruvberger-Saal; Päivikki Kauraniemi; Minna Tanner; Pär-Ola Bendahl; Mikael Lundin; Morten Krogh; Pasi Kataja; Ake Borg; Mårten Fernö; Jorma Isola
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.
Breast cancer research : BCR 2007;9(1):R16.
2007: M Hietala; Therese Sandberg; Ake Borg; Håkan Olsson; Helena Jernström
Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Human reproduction (Oxford, England) 2007;22(1):83-91.
2006: Markus Heidenblad; Karolin H Hallor; Johan Staaf; Göran Jönsson; Ake Borg; Mattias Höglund; Fredrik Mertens; Nils Mandahl
Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
Oncogene 2006;25(53):7106-16.
2006: Linda Holmquist-Mengelbier; Erik Fredlund; Tobias Löfstedt; Rosa Noguera; Samuel Navarro; Helén Nilsson; Alexander Pietras; Johan Vallon-Christersson; Ake Borg; Katarina Gradin; Lorenz Poellinger; Sven Påhlman
Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.
Cancer cell 2006;10(5):413-23.
2006: Jacqueline Schoumans; Bertil Johansson; Martin Corcoran; Ekaterina Kuchinskaya; Irina Golovleva; Dan Grandér; Erik Forestier; Johan Staaf; Ake Borg; Britt Gustafsson; Elisabeth Blennow; Ann Nordgren
Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2.
British journal of haematology 2006;135(4):492-9.
2006: Kajsa Paulsson; Markus Heidenblad; Helena Mörse; Ake Borg; Thoas Fioretos; Bertil Johansson
Identification of cryptic aberrations and characterization of translocation breakpoints using array CGH in high hyperdiploid childhood acute lymphoblastic leukemia.
Leukemia 2006;20(11):2002-7.
2006: Sanna-Maria Karppinen; Rosa B Barkardottir; K Backenhorn; T Sydenham; Kirsi Syrjäkoski; Johanna Schleutker; Tarja Ikonen; Katri Pylkäs; Katrin Rapakko; Hannele Erkko; Gudrun Johannesdottir; Anne-Marie Gerdes; Mads Thomassen; Bjarni A Agnarsson; M Grip; Anne Kallioniemi; Juha Kere; Lauri A Aaltonen; Adalgeir Arason; P Møller; Torben A Kruse; Ake Borg; Robert Winqvist
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
Journal of medical genetics 2006;43(11):856-62.
2006: Josef Davidsson; Markus Heidenblad; Ake Borg; Bertil Johansson
Array-based comparative genomic hybridization characterization of cytogenetically polyclonal myeloid malignancies.
Cancer genetics and cytogenetics 2006;169(2):179-80.
2006: Hrefna Kristin Johannsdottir; Goran Jonsson; Gudrun Johannesdottir; Bjarni A Agnarsson; Hannaleena Eerola; Adalgeir Arason; Paivi Heikkila; Valgardur Egilsson; Hakan Olsson; Oskar T Johannsson; Heli Nevanlinna; Ake Borg; Rosa B Barkardottir
Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
International journal of cancer. Journal international du cancer 2006;119(5):1052-60.
2006: Katri Heikkinen; Katrin Rapakko; Sanna-Maria Karppinen; Hannele Erkko; Sakari Knuutila; Tuija Lundán; Arto Mannermaa; Anne-Lise Børresen-Dale; Ake Borg; Rosa B Barkardottir; John H J Petrini; Robert Winqvist
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
Carcinogenesis 2006;27(8):1593-9.
2006: Helena Jernström; Gunilla Sellberg; Ake Borg; Håkan Olsson
Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006;15(3):233-41.
2006: P Gustavsson; Jacqueline Schoumans; Johan Staaf; Göran Jönsson; F Carlsson; Ulf Kristoffersson; Ake Borg; Magnus Nordenskjöld; N Dahl
Hemizygosity for chromosome 2q14.2-q22.1 spanning the GLI2 and PROC genes associated with growth hormone deficiency, polydactyly, deep vein thrombosis and urogenital abnormalities.
Clinical genetics 2006;69(5):441-3.
2006: Kajsa Paulsson; Markus Heidenblad; Bodil Strömbeck; Johan Staaf; Göran Jönsson; Ake Borg; Thoas Fioretos; Bertil Johansson
High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.
Leukemia 2006;20(5):840-6.
2006: Susanne Malander; Eva Rambech; Ulf Kristoffersson; Britta Halvarsson; Mona Ridderheim; Ake Borg; Mef Nilbert
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Gynecologic oncology 2006;101(2):238-43.
2006: David Lindgren; Fredrik Liedberg; Anna Andersson; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Thoas Fioretos; Mattias Höglund
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
Oncogene 2006;25(18):2685-96.
2006: Amelia Szymanowska; Ewa Jassem; Rafal Dziadziuszko; Ake Borg; Janusz Limon; Grazyna Kobierska-Gulida; Witold Rzyman; Jacek Jassem
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Lung cancer (Amsterdam, Netherlands) 2006;52(1):9-14.
2006: Josefin Fernebro; Princy Francis; Patrik Edén; Ake Borg; Ioannis Panagopoulos; Fredrik Mertens; Johan Vallon-Christersson; Måns Akerman; Anders Rydholm; Henrik C F Bauer; Nils Mandahl; Mef Nilbert
Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.
International journal of cancer. Journal international du cancer 2006;118(5):1165-72.
2006: Helena Jernström; Therese Sandberg; Erika Bågeman; Ake Borg; Håkan Olsson
Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():497.
2006: Eva Henriksson; Bo Baldetorp; Ake Borg; Elisabeth Kjellen; Jan Akervall; Johan Wennerberg; Peter Wahlberg
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
Acta oncologica (Stockholm, Sweden) 2006;45(3):300-5.
2006: Anna Isinger; Misha Bhat; Ake Borg; Mef Nilbert
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum.
BMC cancer 2006;6():64.
2005: Helena Jernström; Niklas Loman; Oskar T Johannsson; Ake Borg; Håkan Olsson
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
European journal of cancer (Oxford, England : 1990) 2005;41(15):2312-20.
2005: Mervi Laakso; Niklas Loman; Ake Borg; Jorma Isola
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1321-8.
2005: Göran Jönsson; Pär-Ola Bendahl; Therese Sandberg; Azra Kurbasic; Johan Staaf; Lone Sunde; Dorthe G Crüger; Christian Ingvar; Håkan Olsson; Ake Borg
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
Journal of the National Cancer Institute 2005;97(18):1377-82.
2005: Göran Jönsson; Tara L Naylor; Johan Vallon-Christersson; Johan Staaf; Jia Huang; M Renee Ward; Joel Greshock; Lena Luts; Håkan Olsson; Nazneen Rahman; Michael Stratton; Markus Ringnér; Ake Borg; Barbara L Weber
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Cancer research 2005;65(17):7612-21.
2005: Jacqueline Schoumans; Johan Staaf; Göran Jönsson; Johanna Rantala; Kerstin Sars Zimmer; Ake Borg; Magnus Nordenskjöld; Britt-Marie Anderlid
Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
European journal of medical genetics 2005;48(3):290-300.
2005: Princy Francis; Josefin Fernebro; Patrik Edén; Anna Laurell; Anders Rydholm; Henryk A Domanski; Thomas Breslin; Cecilia Hegardt; Ake Borg; Mef Nilbert
Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas.
Genes, chromosomes & cancer 2005;43(3):302-8.
2005: Anna Andersson; Patrik Edén; David Lindgren; J Nilsson; Carin Lassen; Jesper Heldrup; Magnus Fontes; Ake Borg; Felix Mitelman; Bertil Johansson; Mattias Höglund; Thoas Fioretos
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
Leukemia 2005;19(6):1042-50.
2005: Lao H Saal; Karolina Holm; Matthew Maurer; Lorenzo Memeo; Tao Su; Xiaomei Wang; Jennifer S Yu; Per-Olof Malmström; Mahesh Mansukhani; Jens Enoksson; Hanina Hibshoosh; Ake Borg; Ramon Parsons
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Cancer research 2005;65(7):2554-9.
2005: Anders Kvist; Carlos Rovira; Ake Borg; Patrik Medstrand
Promoter usage of BRCA1-IRIS.
Nature cell biology 2005;7(4):325-6; author rply 326.
2005: Helena Jernström; Therese Sandberg; Erika Bågeman; Ake Borg; Håkan Olsson
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
British journal of cancer 2005;92(5):857-66.
2005: Amelia Szymanowska; Ewa Jassem; Rafal Dziadziuszko; Marcin Skrzypski; Grazyna Kobierska-Gulida; Karolina Holm; Ake Borg; Witold Rzyman; Janusz Limon; Jacek Jassem
[Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
Pneumonologia i alergologia polska 2005;73(3):264-9.
2004: Mads Thomassen; Torben A Kruse; Karen Ege Olsen; Ake Borg; Anne-Marie Gerdes
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation.
Breast cancer research and treatment 2004;87(3):273-6.
2004: Kirsi Syrjäkoski; Tuula Kuukasjärvi; Kati K Waltering; Karin Haraldsson; Anssi Auvinen; Ake Borg; Tommi Kainu; Olli Kallioniemi; Pasi A Koivisto
BRCA2 mutations in 154 finnish male breast cancer patients.
Neoplasia (New York, N.Y.) 2004;6(5):541-5.
2004: Hrefna Kristin Johannsdottir; Gudrun Johannesdottir; Bjarni A Agnarsson; Hannaleena Eerola; Adalgeir Arason; Oskar T Johannsson; Päivi Heikkilä; Valgardur Egilsson; Hakan Olsson; Ake Borg; Heli Nevanlinna; Rosa B Barkardottir
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
Anticancer research 2004;24(5A):2681-7.
2004: Susanna Obad; Hans Brunnström; Johan Vallon-Christersson; Ake Borg; Kristina Drott; Urban Gullberg
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
Oncogene 2004;23(23):4050-9.
2004: Annika Jögi; Johan Vallon-Christersson; Linda Holmquist; Håkan Axelson; Ake Borg; Sven Påhlman
Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.
Experimental cell research 2004;295(2):469-87.
2004: K Nielsen; Christian Ingvar; Anna Måsbäck; Johan Westerdahl; Ake Borg; Therese Sandberg; Nils Jonsson; J Nagel; Håkan Olsson
Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
The British journal of dermatology 2004;150(3):531-6.
2004: Sofia K Gruvberger-Saal; Patrik Edén; Markus Ringnér; Bo Baldetorp; Gunilla Chebil; Ake Borg; Mårten Fernö; Carsten Peterson; Paul S Meltzer
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
Molecular cancer therapeutics 2004;3(2):161-8.
2004: Susanne Malander; Mona Ridderheim; Anna Måsbäck; Niklas Loman; Ulf Kristoffersson; Håkan Olsson; Mef Nilbert; Ake Borg
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.
European journal of cancer (Oxford, England : 1990) 2004;40(3):422-8.
2003: Karin Rennstam; Minna Ahlstedt-Soini; Bo Baldetorp; Pär-Ola Bendahl; Ake Borg; Ritva Karhu; Minna Tanner; Mika Tirkkonen; Jorma Isola
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
Cancer research 2003;63(24):8861-8.
2003: Ian Krop; Paula Maguire; Jaana Lahti-Domenici; Gabriela Lodeiro; Andrea Richardson; Hrefna Kristin Johannsdottir; Heli Nevanlinna; Ake Borg; Rebecca Gelman; Rosa B Barkardottir; Annika Lindblom; Kornelia Polyak
Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Cancer research 2003;63(9):2024-7.
2003: Magdalena Perkowska; Izabela Brozek; Barbara Wysocka; Karin Haraldsson; Therese Sandberg; Ulla Johansson; Gunilla Sellberg; Ake Borg; Janusz Limon
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
Human mutation 2003;21(5):553-4.
2003: Ingrid Hedenfalk; Markus Ringner; Amir Ben-Dor; Zohar Yakhini; Yidong Chen; Gunilla Chebil; Robert Ach; Niklas Loman; Håkan Olsson; Paul Meltzer; Ake Borg; Jeffrey M. Trent
Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2532-7.
2003: Oskar T Johannsson; Synnöve Staff; Johan Vallon-Christersson; Soili Kytöla; Thorarinn Gudjonsson; Karin Rennstam; Ingrid Hedenfalk; Adewale Adeyinka; Elisabeth Kjellén; Johan Wennerberg; Bo Baldetorp; Ole W Petersen; Håkan Olsson; Stina Oredsson; Jorma Isola; Ake Borg
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier.
Laboratory investigation; a journal of technical methods and pathology 2003;83(3):387-96.
2003: Niklas Loman; Anna Bladström; Oskar T Johannsson; Ake Borg; Håkan Olsson
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.
Breast cancer research : BCR 2003;5(6):R175-86.
2003: Sofia K Gruvberger; Markus Ringnér; Patrik Edén; Ake Borg; Mårten Fernö; Carsten Peterson; Paul S Meltzer
Expression profiling to predict outcome in breast cancer: the influence of sample selection.
Breast cancer research : BCR 2003;5(1):23-6.
2002: Anna Måsbäck; Håkan Olsson; Johan Westerdahl; Therese Sandberg; Ake Borg; Nils Jonsson; Christian Ingvar
Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families.
Melanoma research 2002;12(6):549-57.
2002: Pål Møller; Ake Borg; D G R Evans; Neva E Haites; Marta M Reis; H F A Vasen; Elaine Anderson; C Michael Steel; Jaran Apold; David R Goudie; Anthony Howell; Fiona Lalloo; Lovise Maehle; Helen Gregory; Ketil Heimdal
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.
International journal of cancer. Journal international du cancer 2002;101(6):555-9.
2002: Terri Worley; Johan Vallon-Christersson; Blase Billack; Ake Borg; Alvaro Monteiro
A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.
Cancer biology & therapy 2002;1(5):497-501.
2002: Lao H Saal; Carl Troein; Johan Vallon-Christersson; Sofia Gruvberger; Ake Borg; Carsten Peterson
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.
Genome biology 2002;3(8):SOFTWARE0003.
2002: Anjila Koul; Pär-Ola Bendahl; Ake Borg; Mårten Fernö; M F Lidebring; Thomas Högberg; E L Einarsson; Mona Ridderheim; Roger Willén
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(4):362-71.
2002: Anjila Koul; Roger Willén; Pär-Ola Bendahl; Mef Nilbert; Ake Borg
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Cancer 2002;94(9):2369-79.
2002: Ester Rozenblum; Pia Vahteristo; Therese Sandberg; Jon Thor Bergthorsson; Kirsi Syrjakoski; Don Weaver; Karin Haraldsson; Hrefna Kristin Johannsdottir; Paula Vehmanen; Savita Nigam; Natalie Golberger; Christiane Robbins; Evgenia Pak; Amalia Dutra; Elizabeth Gillander; Dietrich A Stephan; Joan E Bailey-Wilson; Suh-Hang Hank Juo; Tommi Kainu; Adalgeir Arason; Rosa B Barkardottir; Heli Nevanlinna; Ake Borg; Olli Kallioniemi
A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.
Human genetics 2002;110(2):111-21.
2002: Ingrid Hedenfalk; Markus Ringnér; Jeffrey M. Trent; Ake Borg
Gene expression in inherited breast cancer.
Advances in cancer research 2002;84():1-34.
2002: Jan Akervall; Ake Borg; Michael Dictor; Charlotte Jin; Yuesheng Jin; Minna Tanner; Jorma Isola; Fredrik Mertens; Johan Wennerberg
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
International journal of oncology 2002;20(1):45-52.
2001: Pål Møller; Ketil Heimdal; Jaran Apold; A Fredriksen; Ake Borg; Eivind Hovig; Anne I Hagen; Bjørn Hagen; J C Pedersen; Lovise Maehle
Genetic epidemiology of BRCA1 mutations in Norway.
European journal of cancer (Oxford, England : 1990) 2001;37(18):2428-34.
2001: S Staff; Jorma Isola; Oskar T Johannsson; Ake Borg; MM Tanner
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa.
British journal of cancer 2001;85(8):1201-5.
2001: Niklas Loman; Oskar T Johannsson; Ulf Kristoffersson; Håkan Olsson; Ake Borg
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Journal of the National Cancer Institute 2001;93(16):1215-23.
2001: Jon Thor Bergthorsson; Bent Ejlertsen; Jørgen H Olsen; Ake Borg; Kirsten Vang Nielsen; Rosa B Barkardottir; S Klausen; Henning T Mouridsen; K Winther; Kirsten Fenger; A Niebuhr; T L Harboe; Erik Niebuhr
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.
Journal of medical genetics 2001;38(6):361-8.
2001: Jamileh Hashemi; Pär-Ola Bendahl; Therese Sandberg; Anton Platz; S Linder; Ulrika Stierner; Håkan Olsson; Christian Ingvar; Johan Hansson; Ake Borg
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families.
Genes, chromosomes & cancer 2001;31(2):107-16.
2001: Pål Møller; Ake Borg; Ketil Heimdal; Jaran Apold; J Vallon-Christersson; Eivind Hovig; Lovise Maehle
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.
European journal of cancer (Oxford, England : 1990) 2001;37(8):1027-32.
2001: Anjila Koul; Niklas Loman; Susanne Malander; Ake Borg; Mona Ridderheim
Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report.
Gynecologic oncology 2001;80(3):399-402.
2001: Ingrid Hedenfalk; DJ Duggan; Yidong Chen; Michael D Radmacher; Michael Bittner; R Simon; Paul Meltzer; B Gusterson; M Esteller; Olli Kallioniemi; Benjamin S Wilfond; Ake Borg; Jeffrey M. Trent; Mark Raffeld; Zohar Yakhini; Amir Ben-Dor; Edward R Dougherty; Juha Kononen; Lukas Bubendorf; W Fehrle; S Pittaluga; S Gruvberger; Niklas Loman; Oskar T Johannsson; Håkan Olsson; Guido Sauter
Gene-expression profiles in hereditary breast cancer.
The New England journal of medicine 2001;344(8):539-48.
2001: Johan Vallon-Christersson; Charmagne Cayanan; Karin Haraldsson; Niklas Loman; Jon Thor Bergthorsson; Karen Brøndum-Nielsen; A M Gerdes; Pål Møller; Ulf Kristoffersson; Håkan Olsson; Ake Borg; Alvaro Monteiro
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
Human molecular genetics 2001;10(4):353-60.
2001: Sima Salahshor; L Haixin; H Huo; V N Kristensen; Niklas Loman; S Sjöberg-Margolin; Ake Borg; Anne-Lise Børresen-Dale; I Vorechovsky; Annika Lindblom
Low frequency of E-cadherin alterations in familial breast cancer.
Breast cancer research : BCR 2001;3(3):199-207.
2000: Laura Sarantaus; Pia Huusko; Hannaleena Eerola; Virpi Launonen; Paula Vehmanen; Katrin Rapakko; Elizabeth M Gillanders; Kirsi Syrjäkoski; Tommi Kainu; Pia Vahteristo; Ralf Krahe; Kimmo Pääkkönen; J Hartikainen; Carl Blomqvist; T Löppönen; Kaija Holli; Markku Ryynänen; Ralf Bützow; Ake Borg; B Wasteson Arver; E Holmberg; Arto Mannermaa; Juha Kere; Olli Kallioniemi; Robert Winqvist; Heli Nevanlinna
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
European journal of human genetics : EJHG 2000;8(10):757-63.
2000: Päivikki Kauraniemi; Ingrid Hedenfalk; K Persson; DJ Duggan; Minna Tanner; Oskar T Johannsson; Håkan Olsson; Jeffrey M. Trent; Jorma Isola; Ake Borg
MYB oncogene amplification in hereditary BRCA1 breast cancer.
Cancer research 2000;60(19):5323-8.
2000: Hiroyuki Mineta; Katsutoshi Miura; Tetsufumi Ogino; Satoru Takebayashi; Kiyoshi Misawa; Yoh Ueda; I Suzuki; Michael Dictor; Ake Borg; Johan Wennerberg
Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas.
British journal of cancer 2000;83(6):775-81.
2000: Maria Planck; E Wenngren; Ake Borg; Håkan Olsson; Mef Nilbert
Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation.
Genes, chromosomes & cancer 2000;29(1):33-9.
2000: Ake Borg; Therese Sandberg; K Nilsson; Oskar T Johannsson; M Klinker; Anna Måsbäck; Johan Westerdahl; Håkan Olsson; Christian Ingvar
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
Journal of the National Cancer Institute 2000;92(15):1260-6.
2000: S Staff; Nina N Nupponen; Ake Borg; Jorma Isola; MM Tanner
Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers.
Genes, chromosomes & cancer 2000;28(4):432-42.
2000: Niklas Loman; Oskar T Johannsson; Pär-Ola Bendahl; Niklas Dahl; Z Einbeigi; A Gerdes; Ake Borg; Håkan Olsson
Prognosis and clinical presentation of BRCA2-associated breast cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1365-73.
2000: MM Tanner; S Grenman; A Koul; Oskar T Johannsson; P Meltzer; tanja pejovic; Ake Borg; Jorma Isola
Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1833-9.
2000: Adewale Adeyinka; Fredrik Mertens; Lennart Bondeson; Jens Peter Garne; Ake Borg; Bo Baldetorp; Nikos Pandis
Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation.
Cancer genetics and cytogenetics 2000;118(1):42-7.
2000: Ake Borg; Jorma Isola; J Chen; C Rubio; Ulla Johansson; B Werelius; Annika Lindblom
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma.
International journal of cancer. Journal international du cancer 2000;85(6):796-800.
1999: Helena Jernström; Oskar T Johannsson; Niklas Loman; Ake Borg; Håkan Olsson
Reproductive factors in hereditary breast cancer.
Breast cancer research and treatment 1999;58(3):295-301.
1999: Maria Planck; Anjila Koul; Eva Fernebro; Ake Borg; Ulf Kristoffersson; Håkan Olsson; E Wenngren; Peter Mangell; Mef Nilbert
hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from southern Sweden.
International journal of cancer. Journal international du cancer 1999;83(2):197-202.
1999: Pål Møller; G Evans; Neva E Haites; H F A Vasen; Marta M Reis; Elaine Anderson; Jaran Apold; Shirley Hodgson; Diana Eccles; H Olsson; D Stoppa-Lyonnet; Jenny Chang-Claude; Patrick J Morrison; G Bevilacqua; Ketil Heimdal; Lovise Maehle; Fiona Lalloo; Helen Gregory; PE Preece; Ake Borg; NC Nevin; MA Caligo; C Michael Steel
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
Disease markers 1999;15(1-3):207-11.
1999: Ake Borg; Anne Dørum; Ketil Heimdal; Lovise Maehle; Eivind Hovig; Pål Møller
BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
Disease markers 1999;15(1-3):79-84.
1999: Oskar T Johannsson; Niklas Loman; Torgil R Möller; Ulf Kristoffersson; Ake Borg; Håkan Olsson
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.
European journal of cancer (Oxford, England : 1990) 1999;35(8):1248-57.
1999: Thoas Fioretos; Bodil Strömbeck; Therese Sandberg; Bertil Johansson; Rolf Billström; Ake Borg; Per-Gunnar Nilsson; Herman Van Den Berghe; Anne Hagemeijer; Felix Mitelman; Mattias Höglund
Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations.
Blood 1999;94(1):225-32.
1999: K Laake; Virpi Launonen; Dieter Niederacher; S Gudlaugsdottir; S Seitz; P Rio; MH Champème; Ivan Bièche; D Birnbaum; G White; M Sztan; N Sever; S Plummer; A Osorio; Annegien Broeks; Pia Huusko; N Spurr; Ake Borg; A M Cleton-Jansen; L van't Veer; J Benitez; G Casey; B Peterlin; Edith Olah; Anne-Lise Børresen-Dale
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1999;25(3):212-21.
1999: Mef Nilbert; Maria Planck; Eva Fernebro; Ake Borg; A Johnson
Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer.
European journal of cancer (Oxford, England : 1990) 1999;35(6):942-5.
1999: Nina N Nupponen; Kati P Porkka; L Kakkola; Minna Tanner; K Persson; Ake Borg; Jorma Isola; Tapio Visakorpi
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
The American journal of pathology 1999;154(6):1777-83.
1999: K Persson; Nikos Pandis; Fredrik Mertens; Ake Borg; Bo Baldetorp; Dick Killander; Jorma Isola
Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization.
Genes, chromosomes & cancer 1999;25(2):115-22.
1999: Anjila Koul; Mef Nilbert; Ake Borg
A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain.
Genes, chromosomes & cancer 1999;24(3):207-12.
1999: Mika Tirkkonen; Tommi Kainu; Niklas Loman; OT Jóhannsson; Håkan Olsson; R B Barkardóttir; Olli Kallioniemi; Ake Borg
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer.
Genes, chromosomes & cancer 1999;24(1):56-61.
1998: Oskar T Johannsson; Niklas Loman; Ake Borg; Håkan Olsson
Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.
Lancet 1998;352(9137):1359-60.
1998: Hiroyuki Mineta; Ake Borg; Michael Dictor; Peter Wahlberg; Jan Akervall; Johan Wennerberg
p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
British journal of cancer 1998;78(8):1084-90.
1998: Niklas Loman; Oskar T Johannsson; Pär-Ola Bendahl; Ake Borg; Mårten Fernö; Håkan Olsson
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Cancer 1998;83(2):310-9.
1998: MM Tanner; Ritva Karhu; Nina N Nupponen; Ake Borg; Bo Baldetorp; tanja pejovic; Mårten Fernö; Dick Killander; Jorma Isola
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
The American journal of pathology 1998;153(1):191-9.
1998: Susan L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; Judy E Garber; D Stoppa-Lyonnet; Edith Olah; B Csokay; OM Serova; Fiona Lalloo; A Osorio; Michael Stratton; Kenneth Offit; J Boyd; MA Caligo; R J Scott; A Schofield; E Teugels; M Schwab; Lisa A Cannon-Albright; D Timothy Bishop; Douglas Easton; J Benitez; Mary-Claire King; Bruce A J Ponder; B Weber; Peter Devilee; Ake Borg; Steven A Narod; David E Goldgar
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: Karin Haraldsson; Niklas Loman; Q X Zhang; Oskar T Johannsson; Håkan Olsson; Ake Borg
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
Cancer research 1998;58(7):1367-71.
1998: CM Phelan; Ake Borg; Marguerite Cuny; DN Crichton; T Baldersson; T I Andersen; MA Caligo; Rosette Lidereau; Annika Lindblom; S Seitz; D Kelsell; U Hamann; P Rio; S Thorlacius; Janos Papp; Edith Olah; Bruce A J Ponder; Y J Bignon; Siegfried Scherneck; Rosa B Barkardottir; A L Borresen-Dale; Jorunn E Eyfjörd; Charles Theillet; Alastair Thompson; Catharina Larsson
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1998: Helena Jernström; Oskar T Johannsson; Ake Borg; H Ivarsson; Håkan Olsson
BRCA1-positive patients are small for gestational age compared with their unaffected relatives.
European journal of cancer (Oxford, England : 1990) 1998;34(3):368-71.
1998: OT Jóhannsson; Jonas Ranstam; Ake Borg; Håkan Olsson
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):397-404.
1998: Jon Thor Bergthorsson; A Jonasdottir; Gudrun Johannesdottir; Adalgeir Arason; Valgardur Egilsson; Simon A Gayther; Ake Borg; S Hakanson; Sigurdur Ingvarsson; Rosa B Barkardottir
Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients.
Human mutation 1998;Suppl 1():S195-7.
1997: Anjila Koul; Ake Borg; tanja pejovic; Pär-Ola Bendahl; Thomas Högberg; Constantin Iosif; Dick Killander
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up.
Gynecologic oncology 1997;67(3):295-302.
1997: Ingrid Hedenfalk; Bo Baldetorp; Ake Borg; Stina Oredsson
Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry.
Cytometry 1997;29(4):321-7.
1997: Helena Jernström; Håkan Olsson; Ake Borg
Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1997;6(4):330-40.
1997: S Håkansson; Oskar T Johannsson; Ulla Johansson; Gunilla Sellberg; Niklas Loman; A M Gerdes; Erik Holmberg; Niklas Dahl; Nikos Pandis; Ulf Kristoffersson; Håkan Olsson; Ake Borg
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
American journal of human genetics 1997;60(5):1068-78.
1997: Oskar T Johannsson; Jonas Ranstam; Ake Borg; Håkan Olsson
BRCA1 mutations and survival in women with ovarian cancer.
The New England journal of medicine 1997;336(17):1255-6; author reply 1256-7.
1997: Q X Zhang; Ake Borg; D M Wolf; Steffi Oesterreich; Suzanne A W Fuqua
An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer.
Cancer research 1997;57(7):1244-9.
1997: Mika Tirkkonen; Oskar T Johannsson; Bjarni A Agnarsson; Håkan Olsson; Sigurdur Ingvarsson; Ritva Karhu; Minna Tanner; Jorma Isola; Rosa B Barkardottir; Ake Borg; Olli Kallioniemi
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Cancer research 1997;57(7):1222-7.
1997: OT Jóhannsson; Ingrid Idvall; C Anderson; Ake Borg; R B Barkardóttir; V Egilsson; Håkan Olsson
Tumour biological features of BRCA1-induced breast and ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(3):362-71.
1997: Peter Devilee; J Hermans; Jorunn E Eyfjörd; A L Bøorresen; Rosette Lidereau; H Sobol; Ake Borg; Anne-Marie Cleton-Jansen; Edith Oláh; B B Cohen; Siegfried Scherneck; U Hamann; B Peterlin; MA Caligo; Y J Bignon; Christine Maugard
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: Jan Akervall; R J Michalides; Hiroyuki Mineta; Alfons J M Balm; Ake Borg; Michael Dictor; Y Jin; B Loftus; Fredrik Mertens; Johan Wennerberg
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Cancer 1997;79(2):380-9.
1997: Hiroyuki Mineta; Ake Borg; Michael Dictor; Peter Wahlberg; Johan Wennerberg
Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
Oral oncology 1997;33(1):42-6.
1996: Q X Zhang; S G Hilsenbeck; Suzanne A W Fuqua; Ake Borg
Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.
The Journal of steroid biochemistry and molecular biology 1996;59(3-4):251-60.
1996: J van den Berg; Oskar T Johannsson; S Håkansson; Håkan Olsson; Ake Borg
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
British journal of cancer 1996;74(10):1615-9.
1996: Ioannis Panagopoulos; Nikos Pandis; S Thelin; C Petersson; Fredrik Mertens; Ake Borg; Ulf Kristoffersson; Felix Mitelman; Pierre Aman
The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
Cancer research 1996;56(21):4871-5.
1996: Gudrun Johannesdottir; Julius Gudmundsson; Jon Thor Bergthorsson; Adalgeir Arason; Bjarni A Agnarsson; G Eiriksdottir; Oskar T Johannsson; Ake Borg; Sigurdur Ingvarsson; Douglas F Easton; Valgardur Egilsson; Rosa B Barkardottir
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Cancer research 1996;56(16):3663-5.
1996: Xiao-Feng Sun; Oskar T Johannsson; S Håkansson; Gunilla Sellberg; Bo Nordenskjöld; Håkan Olsson; Ake Borg
A novel p53 germline alteration identified in a late onset breast cancer kindred.
Oncogene 1996;13(2):407-11.
1996: C Petersson; Nikos Pandis; Fredrik Mertens; Adewale Adeyinka; Christian Ingvar; A Ringberg; Ingrid Idvall; Lennart Bondeson; Ake Borg; Håkan Olsson; U Kristoffersson; Felix Mitelman
Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families.
Genes, chromosomes & cancer 1996;16(3):185-8.
1996: Ake Borg; U Johannsson; Oskar T Johannsson; S Häkansson; Johan Westerdahl; A Mäsbäck; Håkan Olsson; Christian Ingvar
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
Cancer research 1996;56(11):2497-500.
1996: Mårten Fernö; Pär-Ola Bendahl; Ake Borg; J Brundell; L Hirschberg; Håkan Olsson; Dick Killander
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):793-801.
1996: Oskar T Johannsson; E A Ostermeyer; S Håkansson; L S Friedman; U Johansson; Gunilla Sellberg; K Brøndum-Nielsen; V Sele; Håkan Olsson; Mary-Claire King; Ake Borg
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
American journal of human genetics 1996;58(3):441-50.
1996: Håkan Olsson; Ake Borg
Genetic predisposition to breast cancer.
Acta oncologica (Stockholm, Sweden) 1996;35(1):1-8.
1995: M Jönsson; Oskar T Johannsson; Ake Borg
Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2330-4.
1995: A L Børresen; Tone Ikdal Andersen; Jorunn E Eyfjörd; R S Cornelis; Steinunn Thorlacius; Ake Borg; U Johansson; Charles Theillet; S Scherneck; S Hartman
TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.
Genes, chromosomes & cancer 1995;14(1):71-5.
1995: Ake Borg; Johan Lennerstrand; M Stenmark-Askmalm; Mårten Fernö; A Brisfors; A Ohrvik; Olle Stål; Dick Killander; D Lane; J Brundell
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.
British journal of cancer 1995;71(5):1013-7.
1995: Mårten Fernö; Bo Baldetorp; Pär-Ola Bendahl; Ake Borg; S B Ewers; Håkan Olsson; S Rydén; H Sigurdsson; Dick Killander
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.
Breast cancer research and treatment 1995;36(1):23-34.
1994: A Jónsson; Ake Borg; P Hannesson; K Herrlin; Kjell Jonsson; M Sloth; H Petterson
Film-screen vs. digital radiography in rheumatoid arthritis of the hand. An ROC analysis.
Acta radiologica (Stockholm, Sweden : 1987) 1994;35(4):311-8.
1994: Ake Borg; Bo Baldetorp; Mårten Fernö; Dick Killander; Håkan Olsson; S Rydén; H Sigurdsson
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.
Cancer letters 1994;81(2):137-44.
1994: Ake Borg; Q X Zhang; Oskar T Johannsson; Håkan Olsson
High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas.
Journal of the National Cancer Institute 1994;86(10):792-4.
1994: Mårten Fernö; Bo Baldetorp; Ake Borg; J P Brouillet; Håkan Olsson; H Rochefort; Gunilla Sellberg; H Sigurdsson; Dick Killander
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2042-8.
1994: O Jarlman; Ake Borg; M Braw; M Kehler; K Lyttkens; L Samuelsson
Breast imaging: a comparison of digital luminescence radiographs displayed on TV-monitor and film-screen mammography.
Cancer detection and prevention 1994;18(5):375-81.
1993: Q X Zhang; Ake Borg; Suzanne A W Fuqua
An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Cancer research 1993;53(24):5882-4.
1992: Ake Borg; Q X Zhang; Håkan Olsson; E Wenngren
Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.
Genes, chromosomes & cancer 1992;5(4):311-20.
1992: Ake Borg; Bo Baldetorp; Mårten Fernö; Håkan Olsson; H Sigurdsson
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.
International journal of cancer. Journal international du cancer 1992;51(5):687-91.
1992: Ake Borg; Q X Zhang; P Alm; Håkan Olsson; Gunilla Sellberg
The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
Cancer research 1992;52(10):2991-4.
1992: S B Ewers; R Attewell; Bo Baldetorp; Ake Borg; Mårten Fernö; E Långström; Dick Killander
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Breast cancer research and treatment 1992;24(2):115-26.
1992: Mårten Fernö; Bo Baldetorp; Ake Borg; Håkan Olsson; H Sigurdsson; Dick Killander
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Acta oncologica (Stockholm, Sweden) 1992;31(2):157-65.
1992: S B Ewers; R Attewell; Bo Baldetorp; Ake Borg; E Långström; Dick Killander
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Breast cancer research and treatment 1992;20(2):93-108.
1992: S B Ewers; R Attewell; Bo Baldetorp; Ake Borg; Mårten Fernö; E Långström; S Rydén; Dick Killander
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer.
Acta oncologica (Stockholm, Sweden) 1992;31(7):733-40.
1991: Håkan Olsson; Ake Borg; Mårten Fernö; Jonas Ranstam; H Sigurdsson
Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.
Journal of the National Cancer Institute 1991;83(20):1483-7.
1991: Ake Borg; H Sigurdsson; G M Clark; Mårten Fernö; Suzanne A W Fuqua; Håkan Olsson; Dick Killander; W L McGurie
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.
British journal of cancer 1991;63(1):136-42.
1991: Håkan Olsson; Ake Borg; Mårten Fernö; T R Möller; Jonas Ranstam
Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.
Cancer detection and prevention 1991;15(4):265-71.
1991: Ake Borg; Bo Baldetorp; Mårten Fernö; Dick Killander; Håkan Olsson; H Sigurdsson
ERBB2 amplification in breast cancer with a high rate of proliferation.
Oncogene 1991;6(1):137-43.
1990: H Sigurdsson; Bo Baldetorp; Ake Borg; M Dalberg; Mårten Fernö; Dick Killander; Håkan Olsson; Jonas Ranstam
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.
British journal of cancer 1990;62(5):786-90.
1990: Ake Borg; A K Tandon; H Sigurdsson; G M Clark; Mårten Fernö; Suzanne A W Fuqua; Dick Killander; W L McGuire
HER-2/neu amplification predicts poor survival in node-positive breast cancer.
Cancer research 1990;50(14):4332-7.
1990: H Sigurdsson; Bo Baldetorp; Ake Borg; M Dalberg; Mårten Fernö; Dick Killander; Håkan Olsson
Indicators of prognosis in node-negative breast cancer.
The New England journal of medicine 1990;322(15):1045-53.
1990: Mårten Fernö; Ake Borg; U Johansson; A Norgren; Håkan Olsson; S Rydén; Gunilla Sellberg
Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.
Acta oncologica (Stockholm, Sweden) 1990;29(2):129-35.
1989: Mårten Fernö; Ake Borg; G Horvath; B Lindahl
Enzyme immunoassay of progesterone receptor in cancerous and normal endometrial tissue. A comparison with dextran coated charcoal method.
Anticancer research 1989;9(6):1681-3.
1989: Ake Borg; F Linell; Ingrid Idvall; S Johansson; H Sigurdsson; M Fernö; D Killander
HER2/neu amplification and comedo type breast carcinoma.
Lancet 1989;1(8649):1268-9.
1989: Ake Borg; Mårten Fernö; Ingrid Idvall
Estrogen receptor enzyme immunoassay in fine-needle aspirates from human breast cancer.
Acta oncologica (Stockholm, Sweden) 1989;28(2):187-91.
1989: Mårten Fernö; Ake Borg; U Johansson
Enzyme immunoassay of progesterone receptor in breast cancer biopsy samples. A comparison with the dextran coated charcoal method.
Acta oncologica (Stockholm, Sweden) 1989;28(1):19-22.
1988: S Rydén; Mårten Fernö; Ake Borg; L Hafström; T Möller; A Norgren
Prognostic significance of estrogen and progesterone receptors in stage II breast cancer.
Journal of surgical oncology 1988;37(4):221-6.
1988: Håkan Olsson; T R Möller; Jonas Ranstam; Ake Borg; Mårten Fernö
Early oral contraceptive use as a prognostic factor in breast cancer.
Anticancer research 1988;8(1):29-32.
1987: Mårten Fernö; Ake Borg; Ingrid Idvall
Estramustine binding site in human breast cancer biopsy samples. Its relation to estrogen and progesterone receptor levels, age and menopausal status.
European journal of cancer & clinical oncology 1987;23(10):1505-10.
1987: Håkan Olsson; B Lindahl; Jonas Ranstam; Ake Borg; Mårten Fernö; A Norgren
Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Anticancer research 1987;7(4B):853-6.
1987: Mårten Fernö; Ake Borg; Christian Ingvar; P E Jönsson
Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.
Anticancer research 1987;7(4B):741-3.
1986: Mårten Fernö; Ake Borg; Gunilla Sellberg
Enzyme immuno assay of the estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing.
Acta radiologica. Oncology 1986;25(3):171-5.
1986: Håkan Olsson; Ake Borg; S B Ewers; Mårten Fernö; T Möller; Jonas Ranstam
A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Medical oncology and tumor pharmacotherapy 1986;3(2):77-81.
1982: A Norgren; Ake Borg; Mårten Fernö; U Johansson; B Lindahl; K Tsiobanelis
Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
Anticancer research 1982;2(5):315-20.
1982: B Lindahl; P Alm; Ake Borg; Mårten Fernö; H Grundsell; J E Johnsson; A Norgren; C Tropé
Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
Anticancer research 1982;2(4):203-7.